Aller au contenu principal
Profil bibliographique

Lingmin Zeng

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

32Publications signalées
2347Citations signalées
2Affiliations récentes

Les institutions déclarées

Les domaines associés

Statistical Methods in Clinical TrialsAdvanced Statistical Process MonitoringMitochondrial Function and PathologyLung Cancer Treatments and MutationsPesticide Residue Analysis and Safety

Les publications récentes

2025 other OpenAlex

[Association between HER2 overexpression and recurrence rate in patients with non-muscle-invasive bladder cancer following anthracycline-based intravesical instillation therapy].

Kong M. Li, Minling Liu, Shafei Wu, R P Hong et autres

HER2 high-expression seems to be not only associated with worse clinicopathological features of NMIBC but also a poor RFS in NMIBC patients treated with anthracycline instillation after TURBT.

cn (code pays fourni par la source)

1 citation PubMed
2025 preprint OpenAlex

Mitochondrial calcium influx-driven bioenergetics in the dopaminergic system selectively enable drug reward

Jun Gao, Haixin Zhao, Xiao Han, Lingmin Zeng et autres

Abstract Drugs of abuse hijack the brain’s reward system, driving pathological dopamine surges that underlie compulsive behavior and addiction. However, directly targeting dopamine signaling for treatment risks disrupting natural reward processes. Here, we identify a bioenergetic mechanism that selectively promotes addiction-related dopamine …

cn (code pays fourni par la source)

0 citations bioRxiv (Cold Spring Harbor Laboratory)
2025 other OpenAlex

[Evaluation of survival quality of the occupationally exposed population of subway microwave based on SF-36 scale].

Fang Zhou, Lingmin Zeng, Jianing Zhou, Ke Li et autres

The education level, physical exercise, sleep status and microwave exposure dose are important factors affecting the survival quality of microwave exposed personnel. Occupational health education and behavioral life intervention should be strengthened to improve their survival quality.

cn (code pays fourni par la source)

0 citations PubMed
Accès ouvert 2025 article OpenAlex

Berberine is a Novel Mitochondrial Calcium Uniporter Inhibitor that Disrupts MCU‐EMRE Assembly

Haixin Zhao, Siqi Chen, Nian Cao, Wenjun Wu et autres

Abstract The mitochondrial calcium uniporter (MCU) complex mediates Ca 2+ entry into mitochondria, which plays a crucial role in regulating cellular energy metabolism and apoptosis. Dysregulation of MCU is implicated in various diseases, such as neurodegenerative disorders, cardiac diseases, and cancer. Despite …

cn (code pays fourni par la source)

23 citations Advanced Science
2024 preprint OpenAlex

Berberine is a novel mitochondrial calcium uniporter (MCU) inhibitor that disrupts MCU-EMRE assembly

Haixin Zhao, Siqi Chen, Nian Cao, Wenjun Wu et autres

Summary The mitochondrial calcium uniporter (MCU) complex mediates Ca 2+ entry into mitochondrial, which plays a crucial role in regulating cellular energy metabolism and apoptosis. Dysregulation of MCU is implicated in various diseases, such as neurodegenerative disorders, cardiac diseases and cancer. Despite …

cn (code pays fourni par la source)

1 citation bioRxiv (Cold Spring Harbor Laboratory)
Accès ouvert 2024 conference-abstract OpenAlex

EPCORE FL-2: Phase 3 trial of epcoritamab with rituximab and lenalidomide (R2) vs chemoimmunotherapy or R2 in previously untreated follicular lymphoma.

Kim Linton, Philip A. Thompson, Stefano Luminari, Carla Casulo et autres

TPS7084 Background: Follicular lymphoma (FL) is the most common indolent non-Hodgkin lymphoma. Most patients with advanced-stage FL in need of systemic therapy are treated with an anti-CD20 monoclonal antibody (eg, rituximab [R] or obinutuzumab [G]) with cyclophosphamide, doxorubicin, vincristine, and prednisone [CHOP] …

gb, au, it, us, fr (code pays fourni par la source)

7 citations Journal of Clinical Oncology
Accès ouvert 2023 conference-abstract OpenAlex

EPCORE FL-1: Phase 3 Trial of Subcutaneous Epcoritamab with Rituximab and Lenalidomide (R 2) Vs R 2 Alone in Patients with Relapsed or Refractory Follicular Lymphoma

Lorenzo Falchi, Franck Morschhauser, Kim Linton, Huiqiang Huang et autres

Background: Follicular lymphoma (FL) is the most common form of indolent non-Hodgkin lymphoma (NHL). Several treatment options are approved by the US Food and Drug Administration for second- or later-line FL therapy, including rituximab + lenalidomide (R 2). However, advanced-stage FL remains …

us, fr, gb, cn, au (code pays fourni par la source)

12 citations Blood
Accès ouvert 2023 article OpenAlex

Urinary markers differentially associate with kidney inflammatory activity and chronicity measures in patients with lupus nephritis

Ahmad Akhgar, Dominic Sinibaldi, Lingmin Zeng, Alton B. Farris et autres

OBJECTIVE: Lupus nephritis (LN) is diagnosed by biopsy, but longitudinal monitoring assessment methods are needed. Here, in this preliminary and hypothesis-generating study, we evaluate the potential for using urine proteomics as a non-invasive method to monitor disease activity and damage. Urinary biomarkers …

us (code pays fourni par la source)

9 citations Lupus Science & Medicine

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.